The front line of Eisai’s worldwide medicine creation

DOI
  • Tsukahara Kappei
    hhc Data Creation Center & Tsukuba Research Laboratories, Eisai Co., Ltd.

Bibliographic Information

Other Title
  • グローバルに展開するエーザイの創薬最前線

Search this article

Description

<p>Eisai has commenced new medium-term business plan EWAY 2025 in fiscal 2016 with looking ahead to the future environmental changes around pharmaceutical industry in the next 10 years. Accordingly, Research & Development structure has been transformed as Medicine Creation, with determining “Neurology” and “Oncology” as the strategically important areas to continuously make innovation, by introducing novel concept “Ricchi”, areas where we can become a front-runner. In addition, we also make efforts on ICT-driven innovation in digital technology explosion, as well as global health in order to fulfill our responsibilities to eliminate tropical diseases in emerging and developing countries so that we can realize human health care philosophy in the world.</p>

Journal

  • MEDCHEM NEWS

    MEDCHEM NEWS 27 (3), 118-124, 2017-08-01

    The Pharmaceutical Society of Japan

Keywords

Details 詳細情報について

  • CRID
    1390564227313885824
  • NII Article ID
    130007716552
  • DOI
    10.14894/medchem.27.3_118
  • ISSN
    24328626
    24328618
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top